HOME >> MEDICINE >> NEWS
Europe's first polar-orbiting weather satellite ready for launch

Following the roll out to the launch pad and erection at the launch tower at the weekend, MetOp is ready for launch at 18:28 CEST tomorrow from the Baikonur Cosmodrome in Kazakhstan. The launch of Europe's first polar-orbiting weather satellite is set to make a major contribution to global weather forecasting and climate monitoring.

The roll out to the launch pad and erection of the Soyuz rocket at the launch tower took place on Saturday 14 October. Carried by train, the launcher left the hall where the upper-composite, which comprises the MetOp satellite and the Fregat upper-stage, had been integrated with the third-stage of the launch vehicle. The train slowly pulled its cargo over to the launch pad where the rocket was erected with the help of a huge hydraulic ram. The final countdown rehearsal followed, confirming that the launch will go-ahead tomorrow.

Once launched, MetOp will be renamed 'MetOp-A' as it is the first in a series of three satellites developed as part of a joint undertaking between ESA and the European Organisation for the Exploitation of Meteorological Satellites (EUMETSAT), whereby MetOp forms the space segment of EUMETSAT's Polar System (EPS). In addition, MetOp is the European contribution to a new cooperative venture with the American National Oceanic and Atmospheric Administration (NOAA), so that MetOp and NOAA satellites fly in complementary orbits to maximise the coverage area over which observations are made.

MetOp is Europe's first polar-orbiting satellite dedicated to operational meteorology and with its array of sophisticated instruments, this weather satellite promises to provide data of unprecedented accuracy and resolution on a whole host of different variables such as atmospheric temperature and humidity, wind speed and direction over the ocean, ozone and other trace gases, thus making a major contribution to global weather forecasting and climate monitoring capabilities. The payload also includes a
'"/>

Contact: Simonetta Cheli
simonetta.cheli@esa.int
39-694-180-350
European Space Agency
16-Oct-2006


Page: 1 2

Related medicine news :

1. New launch date for Europes first polar-orbiting weather satellite
2. Survey finds care for Europes adults with congenital heart disease is inadequate
3. Study highlights gaps in Europes preparedness plans for pandemic influenza
4. Envisat sees smoke from Europes worst peacetime fire
5. RAND presents first Victor Fuchs Research Award to economists at Carnegie Mellon University
6. Worcester Polytechnic Institute to host national forum on locating first responders inside buildings
7. Screening for behavioral health first step to getting treatment
8. Polish journalist scoops first prize in prestigious European award
9. Poker match pits an vs. machine in world first match
10. Dasatinib shows high early response rate as first treatment for chronic myelogenous leukemia
11. World first medical treatment announced by researchers

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Europe first polar orbiting weather satellite ready for launch

(Date:4/23/2014)... Cancer Center researchers say clinical trials for a ... (AML) are very promising. Patients treated with CPX-351, ... daunorubicin, are showing better responses than patients treated ... , "Acute myeloid leukemia is an aggressive blood ... especially in older patients," explained Jeffrey Lancet, M.D., ...
(Date:4/23/2014)... The American Society for Radiation Oncology (ASTRO) has ... Radiation Therapy for Endometrial Cancer: An ASTRO Evidence-Based ... therapy in the treatment of endometrial cancer. The ... 2014 issue of Practical Radiation Oncology ... The full-length guideline is available as an open-access ...
(Date:4/23/2014)... that targets an important brain receptor has a dramatic ... relapse behavior, a University at Buffalo animal study has ... may be a novel lead compound for treating cocaine ... research was published as an online preview article in ... the compound, RO5263397, severely blunted a broad range of ...
(Date:4/23/2014)... that can rapidly screen a large cell population ... that population has been seriously lacking," said Virginia ... Royal Society of Chemistry journal Chemical Science ... coworkers have developed a novel technique that detects ... Sci. , 2014, DOI: 10.1039/C4SC00578C, http://pubs.rsc.org/en/content/articlelanding/2014/sc/c4sc00578c#!divAbstract ). ...
(Date:4/23/2014)... Ill. - In a country as wealthy as the United ... 12 seniors do not have access to adequate food due ... food insecure. , Recent research at the University of ... Survey (NHANES) revealed that the seniors who are dealing with ... , "In 2011, 8.35 percent of Americans over age 60 ...
Breaking Medicine News(10 mins):Health News:Moffitt Cancer Center's phase 3 study may be game-changer for acute myeloid leukemia 2Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 2Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 3Health News:Novel compound halts cocaine addiction and relapse behaviors 2Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:More Americans in their golden years are going hungry 2
(Date:1/15/2014)... 2014 BreedIT Corp (OTC: BRDT), through ... of highly sophisticated agro-breeding solutions for plant breeders and ... Company,s board of directors appointed chemistry and pharmaceutical industry ... member of the board. From 1975 to ...
(Date:1/15/2014)... Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... Symphony® CGM System as a non-invasive, wireless continuous glucose ... , Executive Chairman and Interim CEO of Echo Therapeutics, ... Annual Equity Conference. Mr. Doman will ...
(Date:1/15/2014)... , Jan. 15, 2014  Valeant Pharmaceuticals International, Inc. ... that the applicable waiting period under the Hart-Scott-Rodino Antitrust ... previously announced tender offer by its indirect wholly-owned subsidiary, ... shares of common stock of Solta Medical, Inc. (NASDAQ: ...
Breaking Medicine Technology:BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3
Cached News: